Price T Rowe Associates Inc Cel Sci Corp Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Cel Sci Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 26,800 shares of CVM stock, worth $18,760. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,800
Previous 26,800 -0.0%
Holding current value
$18,760
Previous $32,000 9.38%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$3.09 - $5.23 $21,630 - $36,610
7,000 Added 35.35%
26,800 $83,000
Q2 2022

Aug 15, 2022
BUY
$2.58 - $4.99 $9,863 - $19,076
3,823 Added 23.93%
19,800 $89,000
Q1 2022

May 16, 2022
BUY
$3.93 - $7.7 $62,789 - $123,022
15,977 New
15,977 $63,000
Q4 2021

Feb 14, 2022
SELL
$7.1 - $12.82 $150,356 - $271,489
-21,177 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$7.64 - $12.49 $80,220 - $131,145
-10,500 Reduced 33.15%
21,177 $233,000
Q2 2021

Aug 16, 2021
SELL
$8.68 - $27.49 $3,758 - $11,903
-433 Reduced 1.35%
31,677 $275,000
Q1 2021

May 17, 2021
BUY
$12.0 - $27.64 $28,224 - $65,009
2,352 Added 7.9%
32,110 $488,000
Q4 2020

Feb 16, 2021
BUY
$11.05 - $16.62 $328,825 - $494,577
29,758 New
29,758 $347,000

About CEL SCI CORP

CVM Quotes by TradingView
  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $30.4M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email